IGM Biosciences, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Five
IGM Biosciences, Inc. had Lessee, Operating Lease, Liability, to be Paid, Year Five of $7.36 million as of 2024-12-31, per its 10-K filed 2025-03-06.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive · last filed 2025-03-06
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Five $7.36M.
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Five $6.31M.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Five $6.38M.
- 2021-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Five $2.89M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year Five |
|---|---|
| 2024-12-31 | $7.36M 10-K · filed 2025-03-06 |
| 2023-12-31 | $6.31M 10-K · filed 2024-03-07 |
| 2022-12-31 | $6.38M 10-K · filed 2023-03-30 |
| 2021-12-31 | $2.89M 10-K · filed 2022-03-29 |
| 2020-12-31 | $733.00K 10-K · filed 2021-03-30 |
| 2020-03-31 | $3.01M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $3.01M 10-K · filed 2020-03-26 |
| 2019-09-30 | $2.12M 10-Q · filed 2019-11-07 |